PREVENA RESTOR ARTHROFORM
Device
Solventum Corporation
Total Payments
$81,671
Transactions
259
Doctors
191
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $47,663 | 58 | 31 |
| 2023 | $19,684 | 85 | 68 |
| 2022 | $14,324 | 116 | 104 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $42,515 | 5 | 52.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $13,600 | 3 | 16.7% |
| Food and Beverage | $12,160 | 225 | 14.9% |
| Consulting Fee | $7,570 | 7 | 9.3% |
| Travel and Lodging | $5,827 | 19 | 7.1% |
Payments by Type
Research
$42,515
5 transactions
General
$39,156
254 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Prospective, Single-arm, Multi-center, Open Label Trial Evaluating the Continuous Application of Prevena Therapy for up to 14 days | Solventum Corporation | $18,050 | 0 |
| A Prospective, Single-arm, Multi-center, Open Label Trial Evaluating the Continuous Application of Prevena Therapy for up to 14 days | KCI USA, Inc. | $12,740 | 0 |
| A post-market, randomized, controlled, multicenter, embedded pilot study evaluating incision and surrounding soft tissue management and functional outcomes using 3M Prevena Restor Therapy System versus standard surgical dressings in revision total knee arthroplasty (The ADVANCE study) | Solventum Corporation | $10,500 | 0 |
| A Randomized Controlled Trial Evaluating Edema and ROM Using Negative Pressure Therapy Over Closed Incisions and Surrounding Soft Tissue Versus Standard Surgical Dressings in Bilateral Total Knee Arthroplasty: A Pilot Study | KCI USA, Inc. | $1,225 | 0 |
Top Doctors Receiving Payments for PREVENA RESTOR ARTHROFORM
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Annapolis, MD | $42,515 | 5 |
| , MD | Orthopaedic Surgery | New York, NY | $12,878 | 6 |
| , MD | Orthopaedic Surgery | San Antonio, TX | $4,288 | 11 |
| , MD | Orthopaedic Surgery | San Antonio, TX | $2,579 | 4 |
| , M.D | Adult Reconstructive Orthopaedic Surgery | Weston, FL | $2,354 | 4 |
| , M.D | Plastic Surgery | San Antonio, TX | $1,575 | 1 |
| , M.D | Plastic and Reconstructive Surgery | San Antonio, TX | $1,575 | 1 |
| , M.D | Orthopaedic Trauma | Renton, WA | $1,032 | 4 |
| , MD | Orthopaedic Surgery | New York, NY | $679.03 | 5 |
| , M.D | Orthopaedic Surgery | New York, NY | $679.03 | 5 |
| , MD | Student in an Organized Health Care Education/Training Program | Boston, MA | $653.31 | 3 |
| , MD | Orthopaedic Surgery | Greensboro, NC | $578.98 | 4 |
| , M.D | Orthopaedic Surgery | Fishers, IN | $478.98 | 3 |
| , M.D | Adult Reconstructive Orthopaedic Surgery | Philadelphia, PA | $478.97 | 3 |
| , DNP, RN, FNP, CWOCN | Wound Care | Menomonee Falls, WI | $420.00 | 1 |
| , M.D | Orthopaedic Surgery | Salt Lake City, UT | $364.43 | 2 |
| , MD, MPH | Orthopaedic Surgery | Austin, TX | $304.64 | 2 |
| , DPM | Plastic and Reconstructive Surgery | Washington, DC | $262.50 | 1 |
| , M.D | Orthopaedic Surgery | Indianapolis, IN | $210.00 | 3 |
| , M.D | Adult Reconstructive Orthopaedic Surgery | New York, NY | $200.07 | 2 |
| , MD | Orthopaedic Surgery | Stanford, CA | $200.06 | 2 |
| , M.D | Orthopaedic Surgery | Muncie, IN | $200.06 | 2 |
| , MD | Orthopaedic Trauma | San Jose, CA | $200.05 | 2 |
| , MD | Orthopaedic Surgery | San Antonio, TX | $200.05 | 2 |
| , M.D | Orthopaedic Surgery | Winston Salem, NC | $100.00 | 1 |
Ad
Manufacturing Companies
- Solventum Corporation $47,663
- KCI USA, Inc. $34,009
Product Information
- Type Device
- Total Payments $81,671
- Total Doctors 191
- Transactions 259
About PREVENA RESTOR ARTHROFORM
PREVENA RESTOR ARTHROFORM is a device associated with $81,671 in payments to 191 healthcare providers, recorded across 259 transactions in the CMS Open Payments database. The primary manufacturer is Solventum Corporation.
Payment data is available from 2022 to 2024. In 2024, $47,663 was paid across 58 transactions to 31 doctors.
The most common payment nature for PREVENA RESTOR ARTHROFORM is "Unspecified" ($42,515, 52.1% of total).
PREVENA RESTOR ARTHROFORM is associated with 4 research studies, including "A Prospective, Single-arm, Multi-center, Open Label Trial Evaluating the Continuous Application of Prevena Therapy for up to 14 days" ($18,050).